Correlation Between Cannabics Pharmaceuticals and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cannabics Pharmaceuticals and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabics Pharmaceuticals and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabics Pharmaceuticals and Protalix Biotherapeutics, you can compare the effects of market volatilities on Cannabics Pharmaceuticals and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabics Pharmaceuticals with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabics Pharmaceuticals and Protalix Biotherapeutics.
Diversification Opportunities for Cannabics Pharmaceuticals and Protalix Biotherapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cannabics and Protalix is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Cannabics Pharmaceuticals and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Cannabics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabics Pharmaceuticals are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Cannabics Pharmaceuticals i.e., Cannabics Pharmaceuticals and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Cannabics Pharmaceuticals and Protalix Biotherapeutics
Given the investment horizon of 90 days Cannabics Pharmaceuticals is expected to under-perform the Protalix Biotherapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Cannabics Pharmaceuticals is 4.02 times less risky than Protalix Biotherapeutics. The pink sheet trades about -0.21 of its potential returns per unit of risk. The Protalix Biotherapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 128.00 in Protalix Biotherapeutics on September 5, 2024 and sell it today you would earn a total of 35.00 from holding Protalix Biotherapeutics or generate 27.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cannabics Pharmaceuticals vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Cannabics Pharmaceuticals |
| Protalix Biotherapeutics |
Cannabics Pharmaceuticals and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cannabics Pharmaceuticals and Protalix Biotherapeutics
The main advantage of trading using opposite Cannabics Pharmaceuticals and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabics Pharmaceuticals position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Cannabics Pharmaceuticals vs. Pmv Pharmaceuticals | Cannabics Pharmaceuticals vs. MediciNova | Cannabics Pharmaceuticals vs. Pharvaris BV | Cannabics Pharmaceuticals vs. PepGen |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |